JACC: Heart Failure's latest issue focuses on the use of SGLT2 inhibitors in patients with heart failure both with and without type 2 diabetes. Each study is enhanced by a video where Javad Butler, MD, and the other authors talk through the key points and major findings. Additionally, don't miss a panel discussion where the authors delve deeper into the issues raised by their research. Learn more.